About Us*

Missions and Educational Objectives

Cancer Center


The Graduate Institute of Cancer Biology (GICB) was founded in April 2007 as part of the China Medical University School of Medicine. GICB is dedicated to performing high impact basic science research focus on the fundamental problems in molecular and cellular pathways that leasd to the human cancer and providing students with the highest quality of training in diverse area of cancer research.

“GICB” also represent our institutional commitments: Germination, Inspiration, Communication and Benevolence, to produce leaders who will take the foundations in biomedical science to improve health through patient care, research, and education.


Faculty of GICB is committed to excellent research, teaching and services. Our education program is designated to supplement traditional graduate school training with both depth and breadth of knowledge derived from research in the mechanism, prevention, and treatment of cancer. The aim of GICB curriculum is to assure that students have the necessary background, skills and critical thinking to do original research. GICB place a high priority on new advances in cancer signal transduction pathway and translational medicine through multiple mechanisms including recruiting and retaining the most eminent researches and physicians; actively participating in a joint “Cancer Biology and Drug Discovery” Ph.D. program between CMU and Academia Sinica, and seeking for potential partnership with other university and/or cancer center internationally.


  1. GICB is currently the only graduate institution named “Cancer Biology” in Taiwan.  This program grew out of a need for graduate training at the interface between traditional basic science and medicine disciplines.
  2. GICB has tight partnership with the Center for Molecular Medicine (CMM) at China Medical University Hospital. The research program of GICB and CMM is under the direction of Dr. Mien-Chie Hung, who is the Honorary Chairman of CMM, the Academician in Taiwan, and the Professor and Chairman of Molecular Cellular Oncology, MD Anderson Cancer Center in USA.
  3. Faculty are from the most outstanding cancer institutes internationally. Each member is recognized by their specialty and accomplishments in cancer related field with an excellent publication record and a multi-year commitment of granting support by the federal agency. They are eager to train motivated students in accordance with the highest professional standards in the basic science.
  4. There are a significant amount of state-of-the-art equipments and facilities used in the field of biomedical research which are shared by GICB and CMM, including genomic, proteomics and molecular imaging that could accelerate discovery.


The systemic and multidisciplinary training in cancer biology should allow our students to develop their career in biomedical science. Our discovery-oriented research has important contributions in the conceptual framework of targeted therapy of cancer. We believe that future progression will be countable on the rapid translations into therapeutic strategy that will improve the outcome of cancer patients.